Imugene Limited Share Price
Stocks
IMU
AU000000IMU9
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Australian S.E.
06:10:10 16/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 0.0360 AUD | +5.88% |
|
-7.69% | -90.14% |
| 10-06 | Imugene Limited Announces Executive Changes | CI |
| 08-28 | Imugene Limited Reports Earnings Results for the Full Year Ended June 30, 2026 | CI |
| Market Cap | 17.63M 12.27M 10.9M 10.11M 9.2M 17.35M 1.16B 121M 47.63M 608M 46.04M 45.06M 1.94B | P/E 2027 * |
-0.65x | P/E 2028 * | -0.93x |
|---|---|---|---|---|---|
| Enterprise Value | 8.83M 6.14M 5.46M 5.06M 4.61M 8.69M 583M 60.84M 23.86M 304M 23.06M 22.57M 970M | EV / Sales 2027 * |
-
| EV / Sales 2028 * | - |
| Free-Float |
73.9% | Yield 2027 * |
-
| Yield 2028 * | - |
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| IMU | Delayed | |
OTC Markets
| IUGNF | Delayed | |
|
Deutsche Boerse AG
| ILA | Delayed | |
|
Deutsche Boerse AG
| ILA | End-of-day quote | |
|
Börse Stuttgart
| ILA | Delayed |
| 1 day | +5.88% | ||
| 1 week | -7.69% | ||
| Current month | -14.29% | ||
| 1 month | -23.40% | ||
| 3 months | -61.29% | ||
| 6 months | -76.00% | ||
| Current year | -90.14% |
| 1 week | 0.03 |  | 0.04 |
| 1 month | 0.03 | | 0.05 |
| Current year | 0.03 | | 0.41 |
| 1 year | 0.03 | | 0.43 |
| 3 years | 0.03 | | 5.1 |
| 5 years | 0.03 | | 21.25 |
| 10 years | 0.03 | | 21.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
Darren Keamy
DFI | Director of Finance/CFO | - | 03/03/2025 |
Ursula McCurry
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/2021 |
Sharon Yavrom
CTO | Chief Tech/Sci/R&D Officer | - | 31/05/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Paul Hopper
CHM | Chairman | 70 | 30/10/2012 |
Lesley Russell
BRD | Director/Board Member | 66 | 22/04/2019 |
Jakob Dupont
BRD | Director/Board Member | 61 | 06/09/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 19/12/25 | Free | Director | 14,706 | 0.0047% | ||
| 19/12/25 | Free | Director | 29,411 | 0.0093% | ||
| 19/12/25 | Exercice | Director | 14,706 | 0.0047% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +5.88% | -7.69% | -90.27% | -97.48% | 12.27M | |
| -6.60% | -8.56% | +49.38% | +63.51% | 65B | |
| +0.03% | +5.56% | +9.10% | +69.05% | 51.2B | |
| -4.09% | -0.11% | +2.22% | +53.15% | 51.19B | |
| -1.53% | +2.70% | +30.48% | +34.12% | 43.93B | |
| -1.34% | +4.12% | +16.64% | +115.13% | 41.96B | |
| -5.97% | -6.22% | +228.95% | +454.22% | 38.14B | |
| +6.53% | +8.02% | +16.40% | +53.41% | 33.24B | |
| -0.90% | -10.49% | +37.09% | -3.70% | 25.2B | |
| -1.07% | +2.33% | +19.43% | +9.98% | 22.5B | |
| Average | -0.91% | -1.08% | +31.94% | +75.14% | 37.24B | |
| Weighted average by Cap. | -2.20% | -0.50% | +44.24% | +96.53% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -36.17M -25.17M -22.37M -20.73M -18.86M -35.6M -2.39B -249M -97.71M -1.25B -94.44M -92.43M -3.97B | -28.65M -19.93M -17.72M -16.42M -14.94M -28.2M -1.89B -197M -77.4M -987M -74.81M -73.22M -3.15B |
| Net Debt | -8.8M -6.12M -5.44M -5.04M -4.59M -8.66M -581M -60.64M -23.78M -303M -22.98M -22.49M -967M | 8.5M 5.91M 5.26M 4.87M 4.43M 8.37M 561M 58.57M 22.96M 293M 22.2M 21.72M 934M |
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/10/26 | A$0.0360 | +5.88% | 2,269,661 |
| 15/10/26 | A$0.0340 | -5.56% | 3,119,300 |
| 14/10/26 | A$0.0360 | -2.70% | 1,098,831 |
| 13/10/26 | A$0.0370 | -5.13% | 4,031,117 |
| 12/10/26 | A$0.0390 | 0.00% | 2,244,206 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- IMU Stock
Select your edition
All financial news and data tailored to specific country editions
